Johnson & Johnson Common Stock (JNJ)

About JNJ

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

138,200

Website

www.jnj.com/

Fundamentals

1-day range

$264.27$268.38

Market cap

$613.10B

P/E (trailing)

29.93

P/E (forward)

21.78

EPS (trailing)

$8.62

Dividend yield

3.12%

Beta

0.20

Avg. volume

7.88M

Ex-dividend date

August 25, 2026

Dividend pay date

September 8, 2026

Forecasts

22 analyst ratings

Johnson & Johnson Common Stock Competitors

Chosen by industry and closest market cap.

• JNJ

  Johnson & Johnson Common Stock

  $268.02

  ▲ 0.85%
  Market cap $613.10BP/E 29.93
  $173.33$276.47
• ABBV

  AbbVie Inc. Common Stock

  $255.56

  ▼ 1.01%
  Market cap $433.04BP/E 70.24
  $190.75$267.47
• MRK

  Merck & Company Inc. Common Stock (new)

  $148.32

  ▼ 0.82%
  Market cap $315.57BP/E 103.86
  $77.58$156.92
• NVS

  Novartis AG Common Stock

  $153.79

  ▼ 0.56%
  Market cap $293.23BP/E 21.95
  $96.03$131.5
• AZN

  AstraZeneca PLC Ordinary Shares

  $162.69

  ▼ 1.11%
  Market cap $244.97BP/E 23.44
  $10,784$15,730
• NVO

  Novo Nordisk A/S Common Stock

  $45.6

  ▼ 1.43%
  Market cap $208.51BP/E 11.40
  $224.25$409.95
• ABT

  Abbott Laboratories Common Stock

  $112.42

  ▲ 0.74%
  Market cap $185.36BP/E 35.52
  $81.97$137.49

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Dividend Champion, Contender, And Challenger Highlights: Week August 30
  SeekingAlpha · 8/28/2026
• FDA Approves Stelara for Pediatric Ulcerative Colitis
  benzinga · 8/28/2026
• FDA Approves Stelara for Pediatric Ulcerative Colitis
  Benzinga · 8/28/2026
• World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
  Benzinga · 8/28/2026
• Best Dividend Aristocrats For September 2026
  SeekingAlpha · 8/28/2026
• Thursday's session: top gainers and losers in the dow jones index
  ChartMill · 8/27/2026
• Exploring the top movers within the dow jones index during today's session.
  ChartMill · 8/27/2026
• GSK: Still One Of My Top Healthcare Picks
  SeekingAlpha · 8/27/2026
• Explore the top gainers and losers within the dow jones index in today's session.
  ChartMill · 8/26/2026

• Joaquin Duato · August 13, 2026 · Option Exercise

  123.3K @ $115.67
• Joaquin Duato · August 13, 2026 · Sale

  102.3K @ $261
• Joaquin Duato · August 13, 2026 · Sale

  21.0K @ $262
• Elizabeth Forminard · August 6, 2026 · Option Exercise

  9.3K @ $131.94
• Elizabeth Forminard · August 6, 2026 · Sale

  6.6K @ $255.93
• Elizabeth Forminard · August 6, 2026 · Sale

  9.3K @ $257.76
• Joaquin Duato · August 5, 2026 · Sale

  6.5K @ $258.74
• Joaquin Duato · August 5, 2026 · Sale

  42.0K @ $258.06
• Vanessa Broadhurst · July 20, 2026 · Option Exercise

  11.9K @ $131.94
• Vanessa Broadhurst · July 20, 2026 · Option Exercise

  11.1K @ $129.51
• Vanessa Broadhurst · July 20, 2026 · Sale

  23.1K @ $251.27
• Kathryn E. Wengel · June 11, 2026 · Option Exercise

  10.0K @ $115.67
• Kathryn E. Wengel · June 11, 2026 · Sale

  10.0K @ $241.15
• Woods Eugene A. · June 9, 2026 · Grant

  161 @ $232.79
• Daniel E. Pinto · June 9, 2026 · Grant

  134 @ $232.79

Institutional Ownership

March 31, 2026

Total shares held

1.65B

Total value held

$389.05B

Institutional holders

4586